Publicou 6 edições por ano
ISSN Imprimir: 1040-8401
ISSN On-line: 2162-6472
Indexed in
T Cell Immunity to Tumor Antigens
-
El-Shami Khaled M., Tirosh Boaz, Popovic Dan, Carmon Lior, Tzehoval Esther, Vadai Ezra, Feldman Michael, Eisenbach Lea, Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide, International Journal of Cancer, 85, 2, 2000. Crossref
-
Zhong G., Wang J., Xu M., Xie Z., Yu M., Wang J., Zhou T., Gong W., Sun Y., Hu M., Zhang X., Shen B., Guo N., Enhanced Maturation and Functional Capacity of Dendritic Cells Induced by Mannosylated L2 Domain of ErbB2 Receptor, Scandinavian Journal of Immunology, 62, 2, 2005. Crossref
-
Zheng Ying, Cao Kai-Yuan, Ng Sze Park, Chua Daniel T.T., Sham Jonathan S.T., Kwong Dora L.W., Ng Mun Hon, Lu Liwei, Zheng Bo-Jian, Complementary activation of peripheral natural killer cell immunity in nasopharyngeal carcinoma, Cancer Science, 97, 9, 2006. Crossref
-
Sogn John A., The Status of Tumor Immunology and Cancer Immunotherapy, Immunological Investigations, 29, 2, 2000. Crossref
-
Sogn John A, Tumor Immunology, Immunity, 9, 6, 1998. Crossref
-
Bhattacharya R., Bukkapatnam R., Prawoko I., Soto J., Morgan M., Salup R.R., Efficacy of vaccination with plasmid DNA encoding for HER2/neu or HER2/neu-EGFP fusion protein against prostate cancer in rats, International Immunopharmacology, 2, 6, 2002. Crossref
-
Kadhim S., Penney C., Lagraoui M., Heibein J., Attardo G., Zacharie B., Connolly T., Gagnon L., Synergistic anti-tumor activity of a novel immunomodulator, BCH-1393, in combination with cyclophosphamide, International Journal of Immunopharmacology, 22, 9, 2000. Crossref
-
Whiteside Theresa L, Tumor-induced death of immune cells: its mechanisms and consequences, Seminars in Cancer Biology, 12, 1, 2002. Crossref
-
Luo Xian, Slater James M., Gridley Daila S., Radiation and Endostatin Gene Therapy in a Lung Carcinoma Model: Pilot Data on Cells and Cytokines that Affect Angiogenesis and Immune Status, Technology in Cancer Research & Treatment, 5, 2, 2006. Crossref
-
Hiltbold Elizabeth M., Vlad Anda M., Ciborowski Pawel, Watkins Simon C., Finn Olivera J., The Mechanism of Unresponsiveness to Circulating Tumor Antigen MUC1 Is a Block in Intracellular Sorting and Processing by Dendritic Cells, The Journal of Immunology, 165, 7, 2000. Crossref
-
Berer A., Keil F., Haas O., Lechner K., Geissler K., Öhler L., Generation of Leukemia-Derived Dendritic Cells from Patients with AML, in Acute Leukemias VIII, 40, 2001. Crossref
-
Li Jian, Li Weiping, Liang Shaohong, Cai Dewei, Kieny Marie Paule, Jacob Lutz, Linnenbach Alban, Abramczuk Jan W., Bender Hans, Sproesser Katrin, Swoboda Rolf, Somasundaram Rajasekharan, Guerry DuPont, Herlyn Dorothee, Recombinant CD63/ME491/Neuroglandular/NKI/C-3 Antigen Inhibits Growth of Established Tumors in Transgenic Mice, The Journal of Immunology, 171, 6, 2003. Crossref
-
Svane IM, Nikolajsen K, Hansen SW, Kamby C, Nielsen DL, Johnsen HE, Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method, Bone Marrow Transplantation, 29, 8, 2002. Crossref
-
Boesen M, Svane I M, Engel A-M, Rygaard J, R. Thomsen A, Werdelin O, CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene, Clinical and Experimental Immunology, 121, 2, 2008. Crossref
-
Mazzolini G, Narvaiza I, Martinez-Cruz L A, Arina A, Barajas M, Galofré J C, Qian C, Mato J M, Prieto J, Melero I, Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNγ-induced apoptosis, Gene Therapy, 10, 13, 2003. Crossref